Home/Filings/4/0000950170-24-072564
4//SEC Filing

FORMELA JEAN FRANCOIS 4

Accession 0000950170-24-072564

CIK 0001703647other

Filed

Jun 11, 8:00 PM ET

Accepted

Jun 12, 5:25 PM ET

Size

6.0 KB

Accession

0000950170-24-072564

Insider Transaction Report

Form 4
Period: 2024-06-11
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-06-11+5,1905,190 total
    Exercise: $42.19Exp: 2034-06-10Common Stock (5,190 underlying)
Footnotes (2)
  • [F1]The shares subject to the option vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next annual meeting of stockholders, subject to continued service as a non-employee director through the applicable vesting date.
  • [F2]The Reporting Person is a member of Atlas XI and is obligated to transfer the economic benefit, if any, received upon the sale of the shares issuable upon exercise of the option to Atlas Venture Life Science Advisors, LLC. As such, the Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any.

Documents

1 file

Issuer

Korro Bio, Inc.

CIK 0001703647

Entity typeother
IncorporatedMA

Related Parties

1
  • filerCIK 0001030575

Filing Metadata

Form type
4
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 5:25 PM ET
Size
6.0 KB